Contact Us
Doctors typically prescribe medications to lower your risk of a heart attack, especially if you have diabetes, high blood pressure, high cholesterol, or metabolic syndrome. But imagine you and your physician had the option to go beyond medication and actually monitor the condition of your arteries to prevent a cardiac event before it happens. Well, that technology is here at Holy Name.
As part of its commitment to innovation, Holy Name is among the few hospitals in the world — and only two in northern New Jersey — pairing a groundbreaking imaging technology called photon-counting CT with artificial intelligence (AI) to investigate if it can help improve heart disease detection and predict heart attack risk. This new technology delivers more precise, detailed images of the heart arteries and helps physicians recommend treatment plans based on plaque build up in arteries, potentially improving patient outcomes.
Holy Name is leveraging this new technology for a cardiac clinical trial, called TRANSFORM. This groundbreaking study explores whether cardiac CT scans, coupled with AI, can help prevent heart attacks in high risk individuals without known heart disease.
After undergoing a cardiac scan, participants will be placed into one of two groups:
- One group will continue to receive the standard care for their underlying health issues such as type 2 diabetes, prediabetes, high blood pressure, etc.
- The second group will receive an investigational personalized care plan based on how much plaque is detected in their arteries.
Each group will receive additional heart scans, in 2-5 years, to monitor the amount of plaque in their arteries. The findings may help revolutionize future cardiac care.
For information on this clinical trial contact Holy Name's Institute for Clinical Research at [email protected] or at (201) 541-6312.
